Early Palliative Care in Metastatic Lung Cancer in Northern France
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.
- Status
- COMPLETED
- Phase
- PHASE3
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries
- Status
- COMPLETED
- Phase
- PHASE3
Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
- Status
- WITHDRAWN
- Phase
- PHASE2
Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Everolimus Beyond Progression
- Status
- TERMINATED
- Phase
- PHASE2
OPALINE : A Study Of Morbidity And Mortality At 2 Years
- Status
- COMPLETED
- Phase
- N/A
Omalizumab in Severe and Refractory Solar Urticaria
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
- Status
- COMPLETED
- Phase
- N/A
Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)
- Status
- TERMINATED
- Phase
- PHASE1
Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1